Long-Term Safety and Disease Control of Ruxolitinib Cream Among Adolescents With Atopic Dermatitis: Results From Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. s28, 2022. DOI: 10.25251/skin.6.supp.28. Disponível em: https://skin.dermsquared.com/skin/article/view/1545. Acesso em: 17 may. 2025.